Immunology, Histocompatibility Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
Transplantation. 2009 Aug 15;88(3 Suppl):S1-7. doi: 10.1097/TP.0b013e3181af6473.
Recent developments in basic and translational immunology open new exciting perspectives for inducing transplantation tolerance in the clinic. Induction of tolerance, defined as permanent acceptance of the transplant in the absence of continuous immunosuppression, is an achievable goal. However, a number of hurdles still need to be overcome before immunosuppressive drugs can be safely withdrawn in solid organ transplant recipients. Additional strategies for improving long-term outcomes were examined, including best methods for apply using various biomarkers in the clinical setting to improve the diagnosis and management of ongoing renal damage. Detection of a potential or existing immune response to tissue grafts is an important first step in improving the survival of heart, liver, and kidney transplant patients.
基础和转化免疫学的最新进展为临床诱导移植耐受带来了新的令人兴奋的前景。耐受的诱导被定义为在没有持续免疫抑制的情况下对移植的永久性接受,这是一个可以实现的目标。然而,在实体器官移植受者中安全停用免疫抑制剂之前,仍需要克服许多障碍。还研究了改善长期结果的其他策略,包括在临床环境中使用各种生物标志物的最佳方法,以改善对正在进行的肾损伤的诊断和管理。检测对组织移植物的潜在或现有免疫反应是提高心脏、肝脏和肾脏移植患者生存率的重要第一步。